Quarterly ResultNov 5, 2026, 06:36 AM
LeMaitre Vascular Q3 Sales Up, EPS Mixed; Declares $0.25 Dividend
AI Summary
LeMaitre Vascular, Inc. filed its quarterly report for the period ending September 30, 2026. The company reported an increase in net sales for both the third quarter and the first nine months of the year compared to the previous year. However, diluted earnings per share saw a decrease in the third quarter, though it increased for the nine-month period. The balance sheet shows growth in total assets and stockholders' equity, with a slight increase in total liabilities. The company also announced a quarterly cash dividend of $0.25 per share.
Key Highlights
- LeMaitre Vascular reported Q3 2026 net sales of $67.97M, up from $61.05M in Q3 2025.
- Nine-month 2026 net sales reached $204.90M, compared to $185.15M in the prior year period.
- Q3 2026 diluted EPS was $0.65, compared to $0.75 in Q3 2025.
- Nine-month 2026 diluted EPS was $2.07, compared to $1.84 in the prior year period.
- Total assets increased to $656.03M as of September 30, 2026, from $615.69M as of December 31, 2025.
- Total liabilities were $223.90M as of September 30, 2026, up from $222.17M as of December 31, 2025.
- Stockholders' equity grew to $432.13M as of September 30, 2026, from $393.52M as of December 31, 2025.
- The company declared a quarterly cash dividend of $0.25 per share.
Price Impact
More from LMAT